SRP LLC team to collaborate with staff of the Injury Surveillance Program, Massachusetts Department of Public Health, on a project linking crash injury data with hospitalization claims data
August 18, 2016
SRP CEO Catherine Rahilly-Tierney to present a poster at the 86th Annual Meeting of the American Thyroid Association in Denver, CO, September 23, 2016: “Review of Studies Evaluating the Diagnostic Accuracy of the Afirma Gene Expression Classifier in Indeterminate Thyroid Nodules”
July 21, 2016
SRP team to execute a review and meta-analysis of the performance and utility of Veracyte, Inc.’s proprietary diagnostic test
January 22, 2016
Risks and benefits of diagnostic tests discussed by experts in Harvard TH Chan School of Public Health Forum – “Medical Tests: Inaccuracies, Risks and the Public’s Health”
December 11, 2015
SRP team publishes letter to the editor, “Cost-effectiveness of 70-gene signature versus AdjuvantOnline and systemic chemotherapy for risk stratification of patients with node-negative breat cancer. Does accuracy matter?”
April 6, 2015
SRP team to collaborate with Pacira, Inc around demonstrating utility and cost-effectiveness of pharmaceutical product
April 1, 2015
SRP in collaboration with SciMedCon LLC present their findings following a review of Kentucky’s Lung Cancer Research Program
June 25, 2014
SRP and Biogen, Inc. to collaborate on evaluating safety of several products in clinical trials
May 5, 2014